Page last updated: 2024-11-01

nevirapine and Weight Gain

nevirapine has been researched along with Weight Gain in 2 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Weight Gain: Increase in BODY WEIGHT over existing weight.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chetty, T1
Carter, RJ1
Bland, RM1
Newell, ML1
Djadou, KE1
Ocloo, A1
Dokounor, D1
Agbodjan-Djossou, O1
Akakpossa, A1
Atakouma, DY1

Other Studies

2 other studies available for nevirapine and Weight Gain

ArticleYear
HIV status, breastfeeding modality at 5 months and postpartum maternal weight changes over 24 months in rural South Africa.
    Tropical medicine & international health : TM & IH, 2014, Volume: 19, Issue:7

    Topics: Adult; Anti-HIV Agents; Breast Feeding; Female; Follow-Up Studies; HIV Infections; Humans; Infant; I

2014
[Treatment of children born of AIDS mothers in Tsevie hospital regional center, Togo].
    Bulletin de la Societe de pathologie exotique (1990), 2007, Volume: 100, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Breast Feeding; Child Health Services; Femal

2007